Pay in 4 interest-free payments of $5.04 Learn more
Ships within 48 hours · Estimated delivery Nov 9 - Nov 14
642P Phase I study of SHR-A2009, a HER3-targeted ADC, in pretreated EGFR-mutated NSCLC
Nadph oxidases (Nox): an overview from discovery, molecular mechanisms to physiology and pathology
The fat-loss driver and the tissue-repair driver, run together, produce a body transformation that addresses more variables than fat loss alone
Liu lng tiu chun l khong 20 n 40mg cho mi kg cn nng
Combining genetic insights, biomarker assessment, and provider guidance creates a comprehensive picture for personalized supplementation decisions
US$ 22.24
US$ 22.32
US$ 24.89
US$ 26.21
US$ 28.33
US$ 25.24
US$ 29.11
US$ 27.90
US$ 23.72
US$ 1190.00
Sold : Login>>
